How U.S. Baby Infant Formula Market Expected to Reach $5,811 Million by 2027?

According to a new report published by Allied Market Research, titled, U.S. Baby Infant Formula Market by Product Type, Ingredient, Distribution Channel, and Point of Sale (POS): Opportunity Analysis and Industry Forecast, 2021–2027,” the U.S. baby infant formula market size is expected to reach $5,811 million by 2027 at a CAGR of 5.8% from 2021 to 2027.

The U.S. baby infant formula market was valued at $3,653 million in 2019, and is projected to reach $5,811 million by 2027, registering a CAGR of 5.8% from 2021 to 2027. In 2019, the carbohydrate segment accounted for 56.48% of the market share. First few years of an infant are crucial as the infant is in its growth phase, requiring appropriate nutrition. Carbohydrates are the major fuel source of infants, and are essential for proper growth and development. Offering infants healthy, nutrient-dense carbohydrates is expected to optimize their growth and maintain a healthy body weight.

Download Report Sample (PDF with Insights, Charts, Tables, Figures) at: https://www.alliedmarketresearch.com/request-sample/11214

The growth of the U.S. baby infant formula market is majorly driven by rise in female working population. For instance, according to the U.S. Bureau of Statistics, the working women population has increased from 57.1% in 2018 to 57.5% in 2020. Most of the working mothers resume their jobs shortly after their delivery. Hence, breastfeeding is not always possible for working mothers, due to lack of time and inconvenience. Baby infant formula serves as an ideal alternative for working mothers, which meets the requirements of healthy, nutritious food for their babies with their need for convenience. Thus, increase in female workforce notably contributes toward the growth of the U.S. baby infant formula market. Breastfeeding is not always possible for mothers working outside homes; thus, baby infant formula acts as a suitable alternative for infants, as its composition is similar to that of breast milk.

Request for Customization of This Report at: https://www.alliedmarketresearch.com/request-for-customization/11214

Baby infant formulas contain nucleotides necessary for the metabolic processes such as energy metabolism and enzymatic reactions. These nucleotides act as building blocks of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) for normal body functions. In addition, iron-rich infant formula helps to prevent anemia. Various infant formulas are based on probiotics, which help prevent diarrhea, ease colic, and reduce the risk of food allergies. Moreover, baby infant formulas are high in protein, linoleic acid, minerals, calcium, carbohydrates, phosphorus, iodine, sodium chloride, potassium chloride, and other nutrients, which are necessary for proper development of infants. Thus, physicians recommend the use of baby infant formula for babies as a substitute to breast milk, owing to its high nutritional content, thereby driving the market growth.

Interested to Procure The Data? Inquire here at: https://www.alliedmarketresearch.com/purchase-enquiry/11214

Baby infant formula is a highly sensitive food product, as it is a substitute to breast milk and is added to the diet of infants for their proper development. Cases related to adulteration of baby infant formula have been reported across the globe. For instance, traces of melamine were reported to have been found by the U.S. Food and Drug Administration in infant formula sold in the U.S. in 2008. Thus, concerns related to the safety of baby infant formula act as the major restraint for the growth.

Baby infant formula serves as an ideal substitute of mother’s milk, however, it lacks antibodies and the complexity of nutrients found in mother’s milk. Moreover, it is less digestible as compared to breast milk and might contain allergens. Thus, development in technology has resulted in formulation of advanced products with high density of nutrition that match the nutrient complexity of breast milk and overcome the abovementioned disadvantages. These factors collectively are expected to offer potential growth opportunities for the U.S. baby infant formula market during the forecast period.

Schedule a FREE Consultation Call with Our Analysts/Industry Experts to Find Solution for Your Business at: https://www.alliedmarketresearch.com/connect-to-analyst/11214

As per the U.S. baby infant formula market share analysis, in 2019, the infant milk segment garnered the largest share, and is likely to maintain this trend during the forecast period. This is attributed to the fact that infant milk contains vitamins and nutrients, such as iron that can help prevent anemia. Some types of baby infant formulas are supplemented with a probiotic bacteria called Bifidobacterium lactis, which helps to prevent diarrhea, ease colic, and lower the risk of food allergies. Furthermore, infant milk contains nutrients, minerals, and vitamins necessary for the development and growth of the baby. According to the U.S. baby infant formula market trends, the launch activities and promotion of the baby infant formula in the U.S. have led to high penetration of baby infant formula.

In addition, upsurge in awareness among consumers regarding the health benefits associated with organic infant formula has led to increase in preference for organic baby drinks. Thus, baby infant formula free from ingredients such as added sugar, sodium, and preservatives is anticipated to gain traction in the U.S., thereby contributing toward the growth of the U.S. baby infant formula industry. However, according to the U.S. baby infant formula market forecast, the concerns related to food safety and decline in birth rate may hamper the U market growth.

Key finding of the study

In 2019, the infant milk is segment was the highest contributor to the U.S. baby infant formula market, in terms of value, and is expected to grow at a CAGR of 6.0% from 2021 to 2027.
The carbohydrate segment is generated the highest revenue in 2019 and is likely to grow at a CAGR of 5.7% during the forecast period.
The vitamins segment is anticipated to exhibit the highest CAGR of 7.3% from 2021 to 2027.
The hypermarkets segment garnered the highest revenue in 2019 and is estimated to grow at a CAGR of 5.3% during the forecast period.
The pharmacy/medical store distribution channel acquired prominent market share in 2019 and is likely to grow at the highest CAGR of 6.6%.

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com
Allied Market Research Blog: https://blog.alliedmarketresearch.com

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP, based in Portland, Oregon. AMR provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.

This release was published on openPR.